Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$172 Mln
Revenue (TTM)
$61 Mln
Net Profit (TTM)
$0 Mln
ROE
0.2 %
ROCE
-- %
P/E Ratio
26
P/B Ratio
3.9
Industry P/E
61.46
EV/EBITDA
15.8
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$0.8
Face value
--
Shares outstanding
8,386,120
CFO
$21.14 Mln
EBITDA
$35.56 Mln
Net Profit
$20.11 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Electromed (ELMD)
| -28.1 | 4.4 | -14.1 | 48.4 | 25.5 | 7.0 | 27.4 |
|
BSE Sensex
| 4.7 | 1.2 | 6.5 | 6.1 | 16.5 | 18.6 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Electromed (ELMD)
| 168.7 | 4.0 | -19.3 | 32.5 | 13.4 | 69.9 | -16.1 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Electromed (ELMD)
|
21.3 | 172.2 | 61.4 | 7.2 | 11.1 | 16.8 | 26 | 3.9 |
| 13.4 | 9,247.0 | 6,685.2 | 715.6 | 16.4 | 12.3 | 13 | 1.5 | |
| 250.1 | 6,628.2 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 235.5 | 6,430.5 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 0.9 | |
| 96.8 | 5,722.6 | 404.5 | -123.7 | -26.1 | -17.3 | -- | 7.5 | |
| 57.8 | 7,834.4 | 2,510.8 | 185.6 | 8.8 | 4.5 | 43.2 | 1.9 | |
| 71.9 | 8,997.9 | 12,669.0 | 407.0 | 5.4 | 11.8 | 22.4 | 2.7 | |
| 168.1 | 8,955.9 | 1,973.6 | -494.5 | -11.4 | -41 | -- | 9.5 | |
| 254.5 | 9,947.5 | 1,240.1 | 42.2 | 4.1 | 3.6 | 237.8 | 8.2 | |
| 120.1 | 6,677.4 | 645.7 | -25.4 | 6.8 | -1.3 | -- | 3.4 |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and... internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota. Address: 500 Sixth Avenue NW, New Prague, MN, United States, 56071 Read more
Chief Financial Officer
Mr. Bradley M. Nagel
President, Director & CEO
Mr. James L. Cunniff
Headquarters
New Prague, MN
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Electromed Inc (ELMD) stood at $ 61 Mln as on 31-Mar-25
The share price of Electromed Inc (ELMD) is $21.25 (NYSE) as of 23-Jun-2025 16:10 EDT. Electromed Inc (ELMD) has given a return of 25.46% in the last 3 years.
Electromed Inc (ELMD) has a market capitalisation of $ 172 Mln as on 23-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Electromed Inc (ELMD) is 3.92 times as on 23-Jun-2025, a 11% premium to its peers’ median range of 3.52 times.
The P/E ratio of Electromed Inc (ELMD) is 25.99 times as on 23-Jun-2025, a 58% discount to its peers’ median range of 61.46 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Electromed Inc (ELMD) and enter the required number of quantities and click on buy to purchase the shares of Electromed Inc (ELMD).
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota. Address: 500 Sixth Avenue NW, New Prague, MN, United States, 56071
The CEO & director of Mr. Bradley M. Nagel. is Electromed Inc (ELMD), and CFO & Sr. VP is Mr. James L. Cunniff.
There is no promoter pledging in Electromed Inc (ELMD).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
995
|
|
|
906
|
|
|
889
|
|
|
883
|
|
|
777
|
|
|
708
|
|
|
663
|
|
|
663
|
|
|
585
|
| Electromed Inc. (ELMD) | Ratios |
|---|---|
|
Return on equity(%)
|
16.76
|
|
Operating margin(%)
|
11.09
|
|
Net Margin(%)
|
11.66
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Electromed Inc (ELMD) was $0 Mln.
$0.72
(
